SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Mandala Agribusiness Co-Investments I Ltd (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Arcadia Biosciences, Inc. [ RKDA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 05/20/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2015		C		8,705,808	A	(1)	8,705,808	D(2)
Common Stock	05/20/2015		P		375,000	A	$8	9,080,808	I(2)	By Mandala Capital AG Limited

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series D Convertible Preferred Stock	(1)	05/20/2015		C			8,918,750	(1)	(1)	Common Stock	8,705,808	$0.00	0	D(2)

1. Name and Address of Reporting Person* Mandala Agribusiness Co-Investments I Ltd (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)

1. Name and Address of Reporting Person* Mandala Agribusiness Fund (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)

1. Name and Address of Reporting Person* Redfern Dominic (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)

1. Name and Address of Reporting Person* Gujadhur Tej (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)

1. Name and Address of Reporting Person* Gujadhur Sheokumar (Last) (First) (Middle) C/O GFIN CORPORATE SERVICES LTD. 9TH FLOOR, ORANGE TOWER (Street) CYBERCITY, EBENE O4 (City) (State) (Zip)

Explanation of Responses:

1. The Series D Preferred Stock converted into Arcadia Biosciences, Inc. common stock on a conversion ratio of one share of common stock for approximately every 1.0245 shares of preferred stock upon the closing of the issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the issuer's 1-for-4 reverse stock split effected on May 8, 2015.

2. The Series D preferred stock which converted into Arcadia Biosciences, Inc. common stock is held by Mandala Agribusiness Co-Investments I Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur are members of the board of Mandala Agribusiness Fund, which exercises shared voting and investment power over the shares owned by Mandala Agribusiness Co-Investments I Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur disclaim beneficial ownership of all securities listed herein, except to the extent of their respective pecuniary interests therein.

Remarks:

	/s/ Tej Gujadhur - as Director of Mandala Agribusiness Co-Investments I Limited	05/22/2015
	/s/ Tej Gujadhur - as Director of Mandala Agribusiness Fund	05/22/2015
	/s/ Tej Gujadhur	05/22/2015
	/s/ Sheokumar Gujadhur	05/22/2015
	/s/ Dominic Redfern	05/22/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.